Speaker illustration

Mrs Anne Kristine Anstensrud

Oslo University Hospital Rikshospitalet, Oslo (Norway)

Il-6 inhibition in acute ST-elevation myocardial infarction

Event: ESC Congress 2020

Topic: Clinical

Session: Late-Breaking Science in Acute Coronary Syndromes 1

Thumbnail

The ASSAIL-MI trial: a Norwegian multicentre, randomised controlled trial designed to assess the effect of tocilizumab on ischaemia reperfusion injury in ST-elevation myocardial infarction

Event: Heart Failure 2018

Topic: Revascularisation

Session: Coronary Artery Disease – Treatment

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb